|
|
|
| Experience of professor Fan Maorong in treating cough related to idiopathic pulmonary interstitial fibrosis from the perspective of “ben xu luo bi” |
| LIANG Yanxia1 DAI Zhaoxin2 ZHAO Yuan1 WANG Bing1 MU Qingxiang3 FAN Maorong1 |
1.Department of Respiratory, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China;
2.Department of Respiratory, Yantai Muping District Hospital of Traditional Chinese Medicine, Sandong Province, Yantai 264100, China;
3.Acumox and Tuina College, Beijing University of Chinese Medicine, Beijing 100029, China |
|
|
|
Abstract Chronic irritant dry cough is one of the most common symptoms of idiopathic interstitial pulmonary fibrosis (IPF). About 80% of IPF patients have chronic irritant dry cough, with daytime symptoms being the most common, and in severe cases it can lead to serious complications such as syncope and fractures, which can aggravate respiratory distress and hypoxia. However, the traditional cough medicine has poor curative effect, and the patients cough can not be cured, whith has a serious impact on patients’ quality of life and psychological well-being. Through clinical observation and practice, Professor Fan Maorong discusses the pathogenesis of cough associated with IPF from the perspective of “original deficiency and paralysis of the lung”, and treats it by emphasising the innate nature, the interplay of gold and water, nourishing the latter and mediating the middle jiao.
|
|
|
|
|
|
[1] Raghu G，Remy-Jardin M，Richeldi L，et al. Idiopathic Pulmonary Fibrosis （an Update） and Progressive Pulmonary Fibrosis in Adults：An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline [J]. Am J Respir Crit Care Med，2022， 205（9）：e18-e47.
[2] Key AL，Holt K，Schuurmans MM. Objective cough frequency in Idiopathic Pulmonary Fibrosis [J]. Cough，2010，21（6）：4.
[3] van Manen MJG，Birring SS，Vancheri C，et al. Cough in idiopathic pulmonary fibrosis [J]. European Respiratory Review，2016，25（141）：278-286.
[4] Birring SS，Kavanagh JE，Irwin RS，et al. Treatment of interstitial lung disease associated cough： CHEST guideline and expert panel report [J]. Chest，2018，154（4）：904-917.
[5] Gyawali CP，Kahrilas PJ，Savarino E，et al. Modern diagnosis of GERD：the Lyon Consensus [J]. Gut，2018，67（7）：1351- 1362.
[6] Bargagli E，Di Masi M，Perruzza M，et al. The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis [J]. Intern Emerg Med，2019，14（1）：39-43.
[7] Caminati A，Lonati C，Cassandro R，et al. Comorbidities in idiopathic pulmonary fibrosis：an underestimated issue [J]. Eur Respir Rev，2019，28（153）：190044.
[8] Gille T，Didier M，Boubaya M，et al. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis [J]. Eur Respir J，2017，49（6）：1601934.
[9] Glass DS，Grossfeld D，Renna HA，et al. Idiopathic pulmonary fibrosis： Molecular mechanisms and potential treatment approaches [J]. Respir Investig，2020，58（5）：320-335.
[10] Munchel JK，Shea BS. Diagnosis and Management of Idiopathic Pulmonary Fibrosis [J]. R I Med J，2021，104（7）：26-29.
[11] White ES，Thomas M，Stowasser S，et al. Challenges for Clinical Drug Development in Pulmonary Fibrosis [J]. Front Pharmacol，2022，13：823085.
[12] Glass DS，Grossfeld D，Renna HA，et al. Idiopathic pulmonary fibrosis：Current and future treatment [J]. Clin Respir J，2022，16（2）：84-96.
[13] Wu Z，Banya W，Chaudhuri N，et al. PAciFy Cough-a multicentre， double-blind， placebo-controlled， crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough [J]. Trials，2022，23（1）：184.
[14] Wakwaya Y，Ramdurai D，Swigris JJ. Managing Cough in Idiopathic Pulmonary Fibrosis [J]. Chest，2021，160（5）：1774-1782.
[15] 李自力，王钢，张新生.张新生主任中医师治疗特发性肺纤维化相关咳嗽的临床经验[J].中国中医急症，2021， 30（5）：909-911.
[16] 范艺龄，袁沙沙，宗慧琪，等.特发性肺纤维化相关咳嗽的中医治疗策略[J].中医杂志，2022，63（1）：21-25.
[17] 刘勇明，吕晓东，庞立健，等.基于肺络构效理论的肺脏生理功能发微[J].中华中医药学刊，2017，35（10）：2518-2520.
[18] 吴以岭，魏聪，赵珊珊.气与气络学说探讨[J].中医杂志，2017，58（21）：1801-1807.
[19] 苗青，丛晓东，樊茂蓉，等.补肾通络汤治疗特发性肺纤维化28例疗效观察[J].时珍国医国药，2017，28（2）：395-397.
[20] 樊茂蓉，李艳艳，张琼，等.肺痹通方对肺纤维化大鼠胶原蛋白及相关因子的影响[J].中医杂志，2013，54（21）：1859-1862.
[21] 李艳艳，张燕萍，王书臣，等.益气通络法治疗肺络闭阻、气阴两虚型特发性肺纤维化的临床研究[J].时珍国医国药，2014，25（3）：630-632.
[22] 樊茂蓉，苗青，张琼，等.通肺络补宗气方提高特发性肺间质纤维化患者活动耐力的临床研究[J].环球中医药，2017，10（3）：284-287.
[23] 李晗.雾化吸入黄芪多糖配伍丹酚酸B对博来霉素致大鼠肺纤维化模型的影响[J].环球中医药，2021，14（8）：1377-1384.
[24] 樊茂蓉，徐凤芹，王冰，等.补虚通痹方治疗特发性肺间质纤维化疗效观察[J].西部中医药，2019，32（5）：77-80.
[25] 杨吉帆，张涛，李春梅.水蛭提取物对电离辐射诱导的肺泡上皮细胞TGF-β/Smad通路及上皮间质转化影响[J].中国免疫学杂志，2022，38（10）：6.
[26] 林岳岩，张锡流.水蛭治疗恶性肿瘤的研究进展[J].中国医药科学，2021，11（16）：40-42，83. |
|
|
|
